You are here

Home » Content

Facebook and Pharmaceutical Companies: An Industry in Need of Guidance

Journal Name:

  • Online Journal of Communication and Media Technologies

Publication Year:

  • 2012

Key Words:

Author NameUniversity of Author
Abstract (2. Language): 
Companies across product categories are working to learn the nuances of social media as it continues to grow in popularity and wide spread adoption. Pharmaceutical companies are no different, except that they must also adapt government regulation and industry standards to the new medium, making the topic important for pharmaceutical companies, consumers, and policy makers. The paper outlines the use of one specific social media platform, Facebook, by three of the world's largest pharmaceutical companies. In addition the paper includes an exploratory crossover study that examines consumer perceptions of the content on the different sites with regard to informative value, entertainment value, and learning. Results indicate that consumers perceive differences on all three variables. Open-ended responses are used to discuss some potential explanations for these differences.
Bookmark/Search this post with
FULL TEXT (PDF): 
PDF icon arastrmx_159096_2_pp_48-70.pdf
  • 3
48-70
  • English

REFERENCES

References: 

Alkhateeb, F.M., K.A. Clauson, N.M. Khanfar, and D.A. Latif (2008), “Digital Marketing: Legal and Regulatory Risk Associated with Web 2.0 Adoption by Pharmaceutical Companies,” Journal of Medical Marketing, 8 (4), 311-18.
Auton, F. (2004), “The Advertising of Pharmaceuticals Direct to Consumers: A Critical Review of the Literature and Debate,” International Journal of Advertising, 23 (1), 5-52.
Blackshaw, P. and M. Nazzaro (2004). Consumer-Generated Media 101: Word-of-Mouth in the Age of the Web-Fortified Consumer. Intelliseek.com. http://www.intelliseek.com/whitepapers.asp (Accessed on March 1, 2011).
Brownfield, E. D., J.M. Bernhardt, J.L. Phan, M.V. Williams, and R.M. Parker (2004), “Direct-to-Consumer Drug Advertisements on Network Television: An Exploration of Quantity, Frequency, and Placement,” Journal of Health Communication, 9 (6), 491–97.
Department of Health and Human Services (DHHS) (2010), “Food and Drug Administration 21 CFR Part 202,” Federal Register, 75 (59), 15376-15387.
Department of Health and Human Services (DHHS) (2009), “Food and Drug Administration. Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools. Part 15 public hearing”
Online Journal of Communication and Media Technologies
Volume: 2 – Issue: 3 – July - 2012
© Online Journal of Communication and Media Technologies 69
http://www.fda.gov/AboutFDA/CentersOffices/CDER/ucm184250.htm (accessed on April 1, 2011).
Facebook. (2010), “Statistics,” http://www.facebook.com/press/info.php?statistics (Accessed on March 6, 2011).
Fox S. (2010) “Accessing Health Topics on the Internet,” Washington, DC: Pew Internet & American Life Project. http://pewresearch.org/pubs/1875/internet-health-topics-accessing-update... (Accessed on April 11, 2011).
Frosch, D.L., D. Grande, D.M Tarn, and R.L Kravitz (2010), “A Decade of Controversy: Balancing Policy With Evidence in the Regulation of Prescription Drug Advertising,” American Journal of Public Health, 100 (1), 24-32
IMS Health Midas (2009), “Top 15 Global Corporations, 2009,” http://www.imshealth.com/deployedfiles/imshealth/Global/Content/StaticFi... (Accessed on April 1, 2011).
IMS National Sales Perspectives (2010), “Top Theraputic Classes by U.S. Sales,” http://www.imshealth.com/deployedfiles/imshealth/Global/Content/StaticFi... (Accessed on April 1, 2011).
Kaiser Family Foundation (2010), “Prescription Drug Fact Sheet,” http://www.kff.org/rxdrugs/upload/3057-08.pdf (Accessed on March 20, 2010).
Kane, G., R.G. Fishman, J. Gallaugher, and J. Glaser (2009), “Community Relations 2.0.,” Harvard Business Review, 87 (11), 45-50.
Kelly, P. (2004), “Pespective: DTC Advertising’s Benefits Far Outweigh Its Imperfections,” Health Affairs http://content.healthaffairs.org/cgi/content/abstract/hlthaff.w4.246 (Accessed on May 10, 2010).
Lexchin, J. and B. Mintzes (2002), “Direct-to-Consumer Advertising of Prescription Drugs: The Evidence Says No,” Journal of Public Policy & Marketing, 21 (2), 194-201.
Mangold, G. and D. Faulds, (2009) “Social Media: The new Hybrid Element of the Promotion Mix.” Business Horizons, (52) 357-365.
Online Journal of Communication and Media Technologies
Volume: 2 – Issue: 3 – July - 2012
© Online Journal of Communication and Media Technologies 70
Meek, C. (2001), Direct to Consumer Advertising of Prescription Medicines: A Review of International Policy and Evidence, London: Royal Pharmaceutical Society of Great Britain.
Mintzes, Barbara (2002), “For and Against: Direct to Consumer Advertising is Medicalising Normal Human Experience,” British Medical Journal, 324, 908-09.
Moschis, G.P. and G.A. Churchill Jr (1978). "Consumer Socialization: a Theoretical and Empirical Analysis." Journal of Marketing Research, 15 (November), 599-609.
Schwartz, M. (2011), “FDA Again Delays Promised Social Media Guidance,” Medical Marketing and Media, (March 30).
Sharp, J. (2010), “Social Media Being Adopted by Patients, Health Care Providers,” PT in Motion, (September), 26-27.
Shaw, G. (2008). “Department Focus: Marketing – Lessons from the Field.” www.healthleadersmedia.com/content/215014/topic/WS_HLM2_MAG/Department-F... (Accessed on April 12, 2011).
Strange, Kurt C. (2007), “On Track: Intended and Unintended Consequences of Direct-to-consumer Drug Marketing,” Annals of Family Medicine, 5 (2), 175–77.
The Nielson Company (2010), “What Americans Do Online: Social Media And Games Dominate Activity,” http://blog.nielsen.com/nielsenwire/online_mobile/what-americans-do-onli... (Accessed on March 21, 2011).

Thank you for copying data from http://www.arastirmax.com